Junling Wang1, Yanru Qiao. 1. Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Room 221, Memphis, TN 38163, USA. Electronic address: jwang26@uthsc.edu.
Abstract
BACKGROUND: Non-Hispanic Blacks (Blacks) and Hispanics have a lower likelihood of being eligible for medication therapy management (MTM) services than do non-Hispanic Whites (Whites) based on Medicare MTM eligibility criteria. OBJECTIVES: To determine whether MTM eligibility criteria would perform differently over time, this study examined the trend of MTM disparities from 1996-1997 to 2007-2008. METHODS: The study populations were Medicare beneficiaries from the Medical Expenditure Panel Survey. Proportions and the odds of MTM eligibility were compared between Whites and ethnic minorities. The trend of disparities was examined by including in logistic regression models interaction terms between dummy variables for the minority groups and 2007-2008. MTM eligibility thresholds for 2008 and 2010-2011 were analyzed. Main and sensitivity analyses were conducted to represent the entire range of the eligibility criteria. RESULTS: This study found no statistical significant racial or ethnic disparities associated with the MTM eligibility criteria for 2008 among the Medicare population during 1996-1997. However, racial disparities associated with 2010-2011 MTM eligibility criteria were significant according to multivariate analyses among the Medicare population during 1996-1997. During 2007-2008, both racial and ethnic disparities associated with both 2008 MTM eligibility criteria and 2010-2011 eligibility criteria were generally significant. Disparity patterns did not exhibit a statistically significant change from 1996-1997 to 2007-2008. CONCLUSIONS: Racial and ethnic disparities in meeting MTM eligibility criteria may not decrease over time unless MTM eligibility criteria are changed.
BACKGROUND: Non-Hispanic Blacks (Blacks) and Hispanics have a lower likelihood of being eligible for medication therapy management (MTM) services than do non-Hispanic Whites (Whites) based on Medicare MTM eligibility criteria. OBJECTIVES: To determine whether MTM eligibility criteria would perform differently over time, this study examined the trend of MTM disparities from 1996-1997 to 2007-2008. METHODS: The study populations were Medicare beneficiaries from the Medical Expenditure Panel Survey. Proportions and the odds of MTM eligibility were compared between Whites and ethnic minorities. The trend of disparities was examined by including in logistic regression models interaction terms between dummy variables for the minority groups and 2007-2008. MTM eligibility thresholds for 2008 and 2010-2011 were analyzed. Main and sensitivity analyses were conducted to represent the entire range of the eligibility criteria. RESULTS: This study found no statistical significant racial or ethnic disparities associated with the MTM eligibility criteria for 2008 among the Medicare population during 1996-1997. However, racial disparities associated with 2010-2011 MTM eligibility criteria were significant according to multivariate analyses among the Medicare population during 1996-1997. During 2007-2008, both racial and ethnic disparities associated with both 2008 MTM eligibility criteria and 2010-2011 eligibility criteria were generally significant. Disparity patterns did not exhibit a statistically significant change from 1996-1997 to 2007-2008. CONCLUSIONS: Racial and ethnic disparities in meeting MTM eligibility criteria may not decrease over time unless MTM eligibility criteria are changed.
Authors: Junling Wang; Jason M Noel; Ilene H Zuckerman; Nancy A Miller; Fadia T Shaya; C Daniel Mullins Journal: Med Care Res Rev Date: 2006-12 Impact factor: 3.929
Authors: Junling Wang; Ya-Chen Tina Shih; Yolanda Qin; Theo Young; Zachary Thomas; Christina A Spivey; David K Solomon; Marie Chisholm-Burns Journal: Am Health Drug Benefits Date: 2015 Jul-Aug
Authors: Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Christina A Spivey; Samuel Dagogo-Jack; Jim Y Wan; Shelley I White-Means; William C Cushman; Marie A Chisholm-Burns Journal: J Pharm Health Serv Res Date: 2014-06
Authors: Jamie A Browning; Chi Chun Steve Tsang; Rose Zeng; Xiaobei Dong; Joseph Garuccio; Jim Y Wan; Marie A Chisholm-Burns; Christopher K Finch; Jack W Tsao; Junling Wang Journal: Curr Med Res Opin Date: 2022-08-09 Impact factor: 2.705
Authors: Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; JoEllen Jarrett-Jamison; Christina A Spivey; Jim Y Wan; Shelley I White-Means; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns Journal: J Manag Care Spec Pharm Date: 2015-11
Authors: Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Shelley I White-Means; Samuel Dagogo-Jack; William C Cushman Journal: Res Social Adm Pharm Date: 2013-06-10
Authors: Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns Journal: J Pharm Health Serv Res Date: 2018-09-07
Authors: Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie A Chisholm-Burns Journal: Inquiry Date: 2018 Jan-Dec Impact factor: 1.730
Authors: Christina A Spivey; Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns Journal: J Manag Care Spec Pharm Date: 2018-02